Seeing Is Believing
Currently out of the existing stock ratings of Brooks West, 28 are a BUY (90.32%), 1 are a SELL (3.23%), 2 are a HOLD (6.45%).
Analyst Brooks West, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 25.07% achieved within 452 days. Previously, Brooks West worked at PIPER SANDLER.
Brooks West’s has documented 60 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 26-Aug-2016.
Analyst best performing recommendations are on EW (EDWARDS LIFESCIENCES CORP).
The best stock recommendation documented was for EW (EDWARDS LIFESCIENCES CORP) at 7/28/2014. The price target of $15.67 was fulfilled within 9 days with a profit of $1.52 (10.74%) receiving and performance score of 11.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$38
$6.04 (18.90%)
$50
10 days ago
(11-Nov-2024)
1/9 (11.11%)
$3.89 (11.40%)
218
Hold
$40
$8.04 (25.16%)
$38
1 months 20 days ago
(01-Oct-2024)
6/16 (37.5%)
$3.09 (8.37%)
191
Hold
$42
$10.04 (31.41%)
$44
3 months 14 days ago
(07-Aug-2024)
2/13 (15.38%)
$5.41 (14.79%)
151
Buy
$45
$13.04 (40.80%)
$53
4 months 19 days ago
(02-Jul-2024)
7/11 (63.64%)
$12.15 (36.99%)
316
Hold
$40
$8.04 (25.16%)
$40
6 months 11 days ago
(10-May-2024)
9/16 (56.25%)
$4.62 (13.06%)
225
What Year was the first public recommendation made by Brooks West?